← Return to Did anyone undergo Car-T therapy for B cell lymphoma?

Discussion

Did anyone undergo Car-T therapy for B cell lymphoma?

CAR-T Cell Therapy | Last Active: Nov 7, 2023 | Replies (76)
Comment receiving replies
@dazlin

@ann...not a big deal.
I didn't mean for anyone to go out of guidelines. Was simply a vocabulary definition...which I could easily Google...no concerns. Wishing you and your husband the very best! Have a great day!

Jump to this post

Replies to "@Ann...not a big deal. I didn't mean for anyone to go out of guidelines. Was simply..."
Colleen Young, Connect Director | @colleenyoung | Jun 23, 2019

Easier said than done actually, @dazlin. Google returns few clear, plain language answers regarding the definitions of "reactive and predominant lymphoid nodules". Here's an extensive article from Science Direct on
- Lymph nodes https://www.sciencedirect.com/topics/neuroscience/lymph-node

Additionally I found the following:
"Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a type of lymphoma that develops from abnormal B lymphocytes (B cells, which are a type of white blood cell). NLPHL is not very common – around 1 in 20 cases (5%) of Hodgkin lymphoma are NLPHL."
In this case predominant means that lymphocytes are the predominant cell type.

What Are Reactive Lymph Nodes? https://www.healthline.com/health/reactive-lymph-node

I'd be interested in hearing how your hematologist explains these terms to you. Please let us know.

VIEW AND REPLY